[Biochemical and histological spectrum of renal osteodystrophy in Argentina]
- PMID: 12778854
[Biochemical and histological spectrum of renal osteodystrophy in Argentina]
Abstract
Between 1994-2001 we have performed 57 bone biopsies for diagnostic purposes in symptomatic CRF patients. We analyzed here 52 samples where the material was optimal for study, and divided them into 2 periods according to when the biopsy was performed: 1994-1996 and 1997-2001, to verify changes in the spectrum of renal osteodystrophy. Mean serum values were: serum calcium 9.9 +/- 1.8 mg/dl, phosphate 5.8 +/- 3.2 mg/dl, alkaline phosphatase 693.9 +/- 968.9 Ul/L, iPTH 562.0 +/- 598.5 pg/ml, serum aluminum 65.7 +/- 79.3 ug/L and bone aluminum 22.8 +/- 22.4 ug/g. Hyperparathyroidism was the most common histological diagnosis as severe in 13 patients (25%), or as mild in 14 (27%). Ten patients had osteomalacia (19%), adynamic bone disease was diagnosed in 5 (9.6%) and mixed renal osteodystrophy in 10 (19.2%). Low bone turnover patients showed higher bone and serum aluminum than high bone turnover patients. We observed a relative increment in high turnover bone disease in the later period (1997-2001) without changes in low turnover bone disease. These data showed a high prevalence of hyperparathyroidism and aluminum-related low turnover bone disease, with no significant changes between the two time-periods analyzed here.
Similar articles
-
Different patterns of renal osteodystrophy in Iberoamerica.Am J Med Sci. 2000 Aug;320(2):76-80. doi: 10.1097/00000441-200008000-00002. Am J Med Sci. 2000. PMID: 10981479
-
[Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].Nefrologia. 2000 Jul-Aug;20(4):362-72. Nefrologia. 2000. PMID: 11039262 Spanish.
-
The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.Clin Nephrol. 1991 Feb;35(2):78-85. Clin Nephrol. 1991. PMID: 2019018
-
Renal osteodystrophy in dialysis patients: diagnosis and treatment.Artif Organs. 1998 Jul;22(7):530-57. doi: 10.1046/j.1525-1594.1998.06198.x. Artif Organs. 1998. PMID: 9684690 Review.
-
Adynamic bone and chronic renal failure: an overview.Am J Med Sci. 2000 Aug;320(2):81-4. doi: 10.1097/00000441-200008000-00003. Am J Med Sci. 2000. PMID: 10981480 Review.
Cited by
-
Effect of aluminum accumulation on bone and cardiovascular risk in the current era.PLoS One. 2023 Apr 20;18(4):e0284123. doi: 10.1371/journal.pone.0284123. eCollection 2023. PLoS One. 2023. PMID: 37079520 Free PMC article.
-
New options for the management of hyperparathyroidism after renal transplantation.World J Transplant. 2012 Jun 24;2(3):41-5. doi: 10.5500/wjt.v2.i3.41. World J Transplant. 2012. PMID: 24175195 Free PMC article. Review.
-
Use of percutaneous ethanol injection therapy for recurrent secondary hyperparathyroidism after subtotal parathyroidectomy.Int J Nephrol. 2011;2011:246734. doi: 10.4061/2011/246734. Epub 2011 Jun 4. Int J Nephrol. 2011. PMID: 21716690 Free PMC article.
-
Aluminium and lead abnormalities in children on haemodialysis: relationship with some medications.Arch Med Sci. 2010 Jun 30;6(3):420-9. doi: 10.5114/aoms.2010.14266. Arch Med Sci. 2010. PMID: 22371781 Free PMC article.
-
Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.J Bras Nefrol. 2020 Jan 20;42(2):138-146. doi: 10.1590/2175-8239-JBN-2019-0045. J Bras Nefrol. 2020. PMID: 32756862 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources